“ Intestinal Microsporidiosis: A Hidden Risk in Rheumatic Disease Patients Undergoing Anti-Tumor Necrosis Factor Therapy Combined With Disease-Modifying Anti-Rheumatic Drugs? ”. Clinics 66, no. 7 (January 1, 2011): 1171–1175. Accessed June 17, 2024. https://revistas.usp.br/clinics/article/view/19356.